Health-Related Quality of Life in Children with Neurofibromatosis Type 1: Contribution of Demographic Factors, Disease-Related Factors, and Behavior

Journal of Pediatrics

Volumn 154, Issue 3, 2009, Pages

  Krab, Lianne C ^a   Oostenbrink, R ^a   de Goede Bolder, Arja ^a   Aarsen, Femke K ^a   Elgersma, Ype ^a   Moll, Henriëtte A ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; CHILD; DEMOGRAPHY; DISEASE SEVERITY; EMOTIONALITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NEUROFIBROMATOSIS; PAIN; PERFORMANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; SCHOOL CHILD; SELF ESTEEM; SELF REPORT; SENSITIVITY ANALYSIS; SOCIAL ASPECT;

ACHIEVEMENT; ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ATTITUDE TO HEALTH; CHILD; CHILD BEHAVIOR DISORDERS; CHILD WELFARE; DEMOGRAPHY; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MENTAL HEALTH; NEUROFIBROMATOSIS 1; PAIN; PARENT-CHILD RELATIONS; PARENTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT; STRESS, PSYCHOLOGICAL;

EID: 60249097471     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.08.045     Document Type: Article

References (35)

1. Huson S.M., Compston D.A., Clark P., and Harper P.S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26 (1989) 704-711
2. Ferner R.E., Huson S.M., Thomas N., Moss C., Willshaw H., Evans D.G., et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44 (2007) 81-88
3. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 89 (1999) 45-52
4. Krab LC, Aarsen FK, de Goede-Bolder A, Catsman-Berrevoets CE, Arts WF, Moll HA, et al. Impact of Neurofibromatosis type 1 on School Performance. J Child Neurol doi: 10.1177/0883073808316366.
5. Johnson N.S., Saal H.M., Lovell A.M., and Schorry E.K. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr 134 (1999) 767-772
6. Dilts C.V., Carey J.C., Kircher J.C., Hoffman R.O., Creel D., Ward K., et al. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J Dev Behav Pediatr 17 (1996) 229-239
7. Barton B., and North K. Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol 46 (2004) 553-563
8. Hyman S.L., Shores A., and North K.N. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 65 (2005) 1037-1044
9. Descheemaeker M.J., Ghesquiere P., Symons H., Fryns J.P., and Legius E. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children. J Intellect Disabil Res 49 (2005) 33-46
10. Wolkenstein P., Zeller J., Revuz J., Ecosse E., and Leplege A. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 137 (2001) 1421-1425
11. Page P.Z., Page G.P., Ecosse E., Korf B.R., Leplege A., and Wolkenstein P. Impact of neurofibromatosis 1 on Quality of Life: a cross-sectional study of 176 American cases. Am J Med Genet A 140 (2006) 1893-1898
12. Oostenbrink R., Spong K., de Goede-Bolder A., Landgraf J.M., Raat H., and Moll H.A. Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants. J Pediatr 151 (2007) 182-186 6 e1-2
13. Graf A., Landolt M.A., Mori A.C., and Boltshauser E. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. J Pediatr 149 (2006) 348-353
14. Krab L.C., De Goede-Bolder A., Aarsen F.K., Pluijm S.M., Bouman M.J., Van der Geest J.N., et al. Effect of Simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 300 (2008) 287-294
15. Landgraf J., Abetz L., and JE W. The CHQ user's manual (1996), The Health Institute, New England Medical Center, Boston
16. Raat H., Bonsel G.J., Essink-Bot M.L., Landgraf J.M., and Gemke R.J. Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 55 (2002) 67-76
17. Raat H., Landgraf J.M., Bonsel G.J., Gemke R.J., and Essink-Bot M.L. Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res 11 (2002) 575-581
18. Divisie Sociale en Ruimtelijke statistieken, Sector Ontwikkeling en ondersteuning. Standaard Beroepenclassificatie 1992 (2001), Centraal Bureau voor de Statistiek, Voorburg/Heerlen ed.
19. Ablon J. Gender response to neurofibromatosis 1. Soc Sci Med 42 (1996) 99-109
20. Friedman J.M., Gutmann D.H., Maccollin M., and Riccardi V.M. Neurofibromatosis: phenotype, natural history, and pathogenesis. 3rd ed. (1999), The Johns Hopkins University Press, Baltimore
21. Achenbach T.M. Integrative guide for the CBCL/4-8, YRS and TRF profiles (1991), University of Vermont Department of Psychiatry, Burlington, VT
22. Raat H., Landgraf J.M., Oostenbrink R., Moll H.A., and Essink-Bot M.L. Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample. Qual Life Res 16 (2007) 445-460
23. Cohen J. Statistical power analysis for the behavioral sciences (1977), Academic Press, New York
24. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
25. Vogels T., Verrips G.H.W., Koopman H.M., Theunissen N.C.M., Fekkes M., and Kamphuis R.P. TACQOL manual: parent form and child form (2000), Leiden Center for Child Health and Pediatrics LUMC-TNO, Leiden
26. Zoller M.E., and Rembeck B. A psychiatric 12-year follow-up of adult patients with neurofibromatosis type 1. J Psychiatr Res 33 (1999) 63-68
27. Barton B., and North K. The self-concept of children and adolescents with neurofibromatosis type 1. Child Care Health Dev 33 (2007) 401-408
28. Sebold C.D., Lovell A., Hopkin R., Noll R., and Schorry E. Perception of disease severity in adolescents diagnosed with neurofibromatosis type 1. J Adolesc Health 35 (2004) 297-302
29. Heath N.L., and Glen T. Positive illusory bias and the self-protective hypothesis in children with learning disabilities. J Clin Child Adolesc Psychol 34 (2005) 272-281
30. Hoza B., Pelham Jr. W.E., Dobbs J., Owens J.S., and Pillow D.R. Do boys with attention-deficit/hyperactivity disorder have positive illusory self-concepts?. J Abnorm Psychol 111 (2002) 268-278
31. White-Koning M., Arnaud C., Bourdet-Loubere S., Bazex H., Colver A., and Grandjean H. Subjective quality of life in children with intellectual impairment-how can it be assessed?. Dev Med Child Neurol 47 (2005) 281-285
32. Klassen A.F., Miller A., and Fine S. Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder. Child Care Health Dev 32 (2006) 397-406
33. White-Koning M., Arnaud C., Dickinson H.O., Thyen U., Beckung E., Fauconnier J., et al. Determinants of child-parent agreement in quality-of-life reports: a European study of children with cerebral palsy. Pediatrics 120 (2007) e804-e814
34. von Rueden U., Gosch A., Rajmil L., Bisegger C., and Ravens-Sieberer U. Socioeconomic determinants of health related quality of life in childhood and adolescence: results from a European study. J Epidemiol Community Health 60 (2006) 130-135
35. Mautner V.F., Kluwe L., Thakker S.D., and Leark R.A. Treatment of ADHD in neurofibromatosis type 1. Dev Med Child Neurol 44 (2002) 164-170